neurocognitive disorders Archives

PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Canna~Fangled Abstracts

Cannabidiol, a plant-derived compound, is an emerging strategy for treating cognitive impairments: comprehensive review of randomized trials

Journal List Front Pharmacol PMC11422111 As a library, NLM provides access to scientific literature. Inclusion…

Freedom WaresSeptember 11, 2024

Canna~Fangled Abstracts

Cannabidiol for behavior symptoms in Alzheimer’s disease (CANBiS-AD): a randomized, double-blind, placebo-controlled trial

Published online by Cambridge University Press: 08 April 2024 Latha Velayudhan, Marta Dugonjic, Sara Pisani, Lucy…

Freedom WaresApril 11, 2024

Canna~Fangled Abstracts

Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review

Review J Cannabis Res. 2022 Mar 14;4(1):11. doi: 10.1186/s42238-022-00119-y. Anees Bahji 1, Natasha Breward 2 3, Whitney Duff 2, Nafisa Absher 2, Scott B…

Freedom WaresMarch 14, 2022

Canna~Fangled Abstracts

Cannabinoid receptor type 2 agonist JWH-133 decreases cathepsin B secretion and neurotoxicity from HIV-infected macrophages

Sci Rep. 2022 Jan 7;12(1):233. doi: 10.1038/s41598-021-03896-3. Lester J Rosario-Rodríguez 1, Yamil Gerena 2, Luis A García-Requena 3, Luz J Cartagena-Isern 4, Juan…

Freedom WaresJanuary 7, 2022

neurocognitive disorders

Cannabidiol, a plant-derived compound, is an emerging strategy for treating cognitive impairments: comprehensive review of randomized trials

Cannabidiol for behavior symptoms in Alzheimer’s disease (CANBiS-AD): a randomized, double-blind, placebo-controlled trial

Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review

Cannabinoid receptor type 2 agonist JWH-133 decreases cathepsin B secretion and neurotoxicity from HIV-infected macrophages

Recent Posts

Archives

Categories